Benjamin Chong, MD
After graduating with a M.D. at Johns Hopkins School of Medicine, Dr. Benjamin Chong pursued dermatology residency training at Henry Ford Hospital in Detroit, MI, where he was selected Chief Resident. In 2008, Dr. Chong joined the Department of Dermatology at University of Texas Southwestern Medical Center in Dallas, TX, and completed a Masters in Clinical Science degree in 2012. He is currently the director of the University of Texas Southwestern Connective Tissue Disease Clinic and the medical director of Parkland Hospital and Health System Dermatology Clinic. He was recently promoted to Associate Professor in 2017, and is the current recipient of the Anita C. Gilliam, MD, PhD, Professorship in Dermatology
Dr. Chong conducts clinical and translational research in cutaneous lupus, an autoimmune and photosensitive skin condition in patients with systemic lupus erythematosus. He is the principal investigator of the University of Texas Southwestern Cutaneous Lupus Registry which contains clinical and historical data, and blood and skin samples from 300 patients. The registry serves as a foundation for multiple clinical and translational research studies, which include developing outcome measures for clinical trials in cutaneous lupus, investigating serum biomarkers that correlate with disease progression, and elucidating the pathophysiology of cutaneous lupus erythematosus. He has received research funding from the Dermatology Foundation, American College of Rheumatology and Arthritis Foundation, and the National Institutes of Health. Finally, Dr. Chong has authored a total of 74 peer-reviewed journal manuscripts, and six book chapters.
Financial relationships
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:Daavlin CorporationDate added:Date updated:08/31/2023
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:Biogen IncorporatedDate added:Date updated:08/31/2023
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:Pfizer IncorporatedDate added:Date updated:08/31/2023
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:Bristol Meyers SquibbDate added:Date updated:08/31/2023
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:Biogen IncorporatedDate added:Date updated:08/31/2023
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:Horizon TherapeuticsDate added:02/01/2022Date updated:08/31/2023
-
Attribution:SelfType of financial relationship:GiftIneligible company:MAPI Research TrustTopic:Receiving RoyaltiesDate added:02/10/2022Date updated:08/31/2023
**Disclaimer**
This Continuing Medical Education (CME) Learning Management System, Ethos, includes individuals designated as 'faculty' for CME purposes. Please note that the term 'faculty' refers solely to their role as a contributor/planner within a CME activity and does not imply any formal affiliation with UT Southwestern Medical Center (UTSW). The display of names and credentials is intended for educational purposes only and does not necessarily indicate a professional or academic relationship with UTSW. Participants are encouraged to verify the affiliations and credentials of faculty members independently if further clarification is needed.